vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
Limbach Holdings, Inc. is the larger business by last-quarter revenue ($138.9M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 3.2%, a 19.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 4.3%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
FDMT vs LMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $138.9M |
| Net Profit | $19.4M | $4.4M |
| Gross Margin | — | 22.4% |
| Operating Margin | 17.3% | 0.8% |
| Net Margin | 22.8% | 3.2% |
| Revenue YoY | 8508900.0% | 4.3% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $138.9M | ||
| Q4 25 | $85.1M | $186.9M | ||
| Q3 25 | $90.0K | $184.6M | ||
| Q2 25 | $15.0K | $142.2M | ||
| Q1 25 | $14.0K | $133.1M | ||
| Q4 24 | $1.0K | $143.7M | ||
| Q3 24 | $3.0K | $133.9M | ||
| Q2 24 | $5.0K | $122.2M |
| Q1 26 | — | $4.4M | ||
| Q4 25 | $19.4M | $12.3M | ||
| Q3 25 | $-56.9M | $8.8M | ||
| Q2 25 | $-54.7M | $7.8M | ||
| Q1 25 | $-48.0M | $10.2M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-43.8M | $7.5M | ||
| Q2 24 | $-35.0M | $6.0M |
| Q1 26 | — | 22.4% | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 28.0% | ||
| Q1 25 | — | 27.6% | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | — | 27.0% | ||
| Q2 24 | — | 27.4% |
| Q1 26 | — | 0.8% | ||
| Q4 25 | 17.3% | 9.4% | ||
| Q3 25 | -67983.3% | 7.2% | ||
| Q2 25 | -396373.3% | 7.5% | ||
| Q1 25 | -383007.1% | 5.9% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | -1704400.0% | 8.1% | ||
| Q2 24 | -849120.0% | 6.7% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 22.8% | 6.6% | ||
| Q3 25 | -63195.6% | 4.8% | ||
| Q2 25 | -364386.7% | 5.5% | ||
| Q1 25 | -342657.1% | 7.7% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -1461433.3% | 5.6% | ||
| Q2 24 | -699060.0% | 4.9% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.43 | $1.01 | ||
| Q3 25 | $-1.01 | $0.73 | ||
| Q2 25 | $-0.98 | $0.64 | ||
| Q1 25 | $-0.86 | $0.85 | ||
| Q4 24 | — | $0.81 | ||
| Q3 24 | $-0.79 | $0.62 | ||
| Q2 24 | $-0.63 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $15.8M |
| Total DebtLower is stronger | — | $56.6M |
| Stockholders' EquityBook value | $505.7M | $196.3M |
| Total Assets | $566.7M | $377.0M |
| Debt / EquityLower = less leverage | — | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $15.8M | ||
| Q4 25 | $402.7M | $11.3M | ||
| Q3 25 | $305.1M | $9.8M | ||
| Q2 25 | $293.2M | $38.9M | ||
| Q1 25 | $321.4M | $38.1M | ||
| Q4 24 | $424.9M | $44.9M | ||
| Q3 24 | $501.9M | $51.2M | ||
| Q2 24 | $541.9M | $59.5M |
| Q1 26 | — | $56.6M | ||
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M |
| Q1 26 | — | $196.3M | ||
| Q4 25 | $505.7M | $195.7M | ||
| Q3 25 | $369.0M | $181.6M | ||
| Q2 25 | $420.9M | $170.5M | ||
| Q1 25 | $469.7M | $161.1M | ||
| Q4 24 | $510.6M | $153.5M | ||
| Q3 24 | $552.9M | $142.2M | ||
| Q2 24 | $588.3M | $133.0M |
| Q1 26 | — | $377.0M | ||
| Q4 25 | $566.7M | $381.1M | ||
| Q3 25 | $424.0M | $409.1M | ||
| Q2 25 | $473.6M | $343.0M | ||
| Q1 25 | $515.7M | $336.4M | ||
| Q4 24 | $560.4M | $352.1M | ||
| Q3 24 | $604.0M | $324.4M | ||
| Q2 24 | $620.1M | $303.9M |
| Q1 26 | — | 0.29× | ||
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $28.1M | ||
| Q3 25 | $-46.5M | $13.3M | ||
| Q2 25 | $-43.4M | $2.0M | ||
| Q1 25 | $-47.8M | $2.2M | ||
| Q4 24 | $-134.6M | $19.3M | ||
| Q3 24 | $-29.4M | $4.9M | ||
| Q2 24 | $-30.2M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | $27.9M | ||
| Q3 25 | $-46.6M | $12.8M | ||
| Q2 25 | $-43.4M | $1.2M | ||
| Q1 25 | $-48.4M | $11.0K | ||
| Q4 24 | $-138.4M | $18.0M | ||
| Q3 24 | $-31.2M | $4.6M | ||
| Q2 24 | $-30.6M | $13.2M |
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | 14.9% | ||
| Q3 25 | -51765.6% | 7.0% | ||
| Q2 25 | -289620.0% | 0.8% | ||
| Q1 25 | -345635.7% | 0.0% | ||
| Q4 24 | -13837100.0% | 12.5% | ||
| Q3 24 | -1038966.7% | 3.4% | ||
| Q2 24 | -611840.0% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 101.1% | 0.3% | ||
| Q2 25 | 440.0% | 0.6% | ||
| Q1 25 | 4507.1% | 1.7% | ||
| Q4 24 | 378600.0% | 0.9% | ||
| Q3 24 | 59266.7% | 0.3% | ||
| Q2 24 | 6980.0% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | 2.29× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 2.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
LMB
| ODR | $99.8M | 72% |
| GCR | $39.0M | 28% |
